Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 34,381,125 shares of the Issuer's common stock outstanding as of March 1st, 2025, in accordance with the 10K filed on March 10th,2025. However, as more fully described in Item 4, the securities reported in rows (6), (8), and (9) show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8), and (9). (6) 2,703,661 shares of Common Stock 4,575,385 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 2,703,661 shares of Common Stock 4,575,385 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 2,703,661 shares of Common Stock 4,575,385 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 2,703,661 shares of Common Stock 4,575,385 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G



 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:President
Date:05/12/2025
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:05/12/2025
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:05/12/2025
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:05/12/2025